-
Zheng shocks Swiatek in another incredible US Open comeback
-
CapTLX Launches Institutional Gateway to U.S. Private Markets, Expanding Access to Structured Investment Opportunities
-
Andreeva survives in three sets against Potapova
-
Africa's richest man eyes continent's largest IPO
-
Alleged killers of Australian, US surfers go on trial in Mexico
-
Macron, SKorea leader warn at film summit of AI risks to creativity
-
King Charles classes Harry and Meghan as 'private citizens'
-
'Impressive' Alcaraz has Shelton in sights in US Open quarter-final
-
Bowling coach Noffke says Pakistan's off-field issues are nothing new
-
Noosha Aubel a krize v Postupimi: Jak dlouho je ještě možné tolerovat toto selhání vedení?
-
Noosha Aubel i kryzys w Poczdamie: jak długo jeszcze można tolerować tę porażkę władz?
-
Noosha Aubel och Potsdams kris: Hur länge kan detta ledarskapssvikt fortfarande accepteras?
-
ヌーシャ・オーベルとポツダムの危機:この指導力の欠如は、いつまで容認され続けるのか?
-
Η Noosha Aubel και η κρίση του Πότσνταμ: Για πόσο ακόμα είναι ανεκτή αυτή η διαχειριστική αποτυχία;
-
नूशा ऑबेल और पॉट्सडैम का संकट: नेतृत्व की इस विफलता को और कितना सहन किया जा सकता है?
-
누샤 아우벨과 포츠담의 위기: 이러한 리더십 부재는 얼마나 더 용인될 수 있는가?
-
努莎·奧貝爾與波茨坦的危機:這種領導失職還能容忍多久?
-
نوشا أوبيل وأزمة بوتسدام: إلى متى سيظل هذا الفشل القيادي مقبولاً؟
-
Нуша Аубель і криза в Потсдамі: як довго ще можна миритися з цією неспроможністю керівництва?
-
Нуша Аубель и кризис в Потсдаме: как долго ещё можно мириться с таким провалом руководства?
-
Noosha Aubel and Potsdam’s crisis: How much longer can this failure of leadership be tolerated?
-
England quick Archer in 'good place' after injuries
-
US envoy sees 'movement' toward three-way talks with Russia, Ukraine
-
Robots protest rampant AI in Poland
-
Thousands bid farewell to Bosnian Serb war criminal in Belgrade
-
Rare woman director in Venice sees industry backsliding on gender
-
EU chief announces 200-mn-euro investment package for Greenland
-
France, SKorea warn at film summit of AI risks to creativity
-
Lebanon says Israel conducts wave of deadly strikes
-
Z Traders Introduces New Funding Model Designed to Expand Opportunities in Trading
-
Cipheras Group - Apex AI Fund Deploys 290-Billion-Parameter Proprietary Large Language Model
-
Lebanon says 12 killed in strikes as Israel vows to 'remove threats'
-
Germany's Merz 'shocked' by far-right state win but vows to stay course
-
Volkswagen plant to be converted for Israeli defence group
-
UK finance minister Healey pledges strict fiscal discipline as budget looms
-
Israeli rubble-clearing in Gaza could erase 'atrocity crimes' evidence: UN expert
-
Mbappe embraces Ballon d'Or talk after historic World Cup exploits
-
Scorching summer pushes French wine harvest to new historic low
-
Tech firms rally, with eyes on US inflation update
-
Pietersen joins England coaching team ahead of World Cup
-
Jaguar Land Rover to cut 4,000 jobs as European car sector hits skids
-
Germany's triumphant far-right AfD aims fire at Merz
-
US average diesel price rises to record $5.90 a gallon: AAA
-
Fury claims Joshua bout is off, calls for Usyk trilogy
-
Dukascopy Bank Unveils AI-Powered Trading, 25,000+ Stock CFDs and a New Flagship E-Banking App
-
British family bids to row back against suicide taboo
-
Tech firms rally but Asian markets mixed, with eyes on US inflation
-
China's teenage 223cm basketball player 'just a little girl'
-
Nepal holds day of mourning as families pray missing still alive
-
Tokyo's Shinjuku to ban more than half of vacation rentals
Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research, on Wednesday, August 20, 2025, at 11:00 a.m. ET.
Ainos will highlight the uniqueness of its AI Nose technology, underscoring recent strategic partnerships and the rapid acceleration of AI Nose deployment. In addition, the Company will also share insights into market and scale-up opportunities across multiple sectors, outline key milestones expected for the remainder of 2025 and into 2026, and make the case for why Ainos should be regarded as a technology company at its core.
To register for this listen-only event, please visit:
Fireside Chat Registration Link
The replay of the fireside chat will be available under "Events" on Ainos' investor relations website at https://ir.ainos.com/.
About AI Nose
AI Nose digitizes scent into Smell ID, an AI-driven scent intelligence. This full-stack electronic nose (e-nose) platform combines precision MEMS sensor arrays with proprietary AI algorithms, aiming to detect scent at parts-per-billion (ppb) sensitivity. Smell ID then converts analog scent data into actionable insights, while the proprietary smell language model (SLM) learns complex scent patterns. Backed by a 13-year scent data moat and deep medtech expertise, AI Nose aims to deliver continuous monitoring, predictive analytics, and instant alerts to boost safety, quality, and efficiency. To be delivered as SmellTech-as-a-Service, it aims to offer subscription access to ongoing scent intelligence, analytics, and real-time alerts, turning the invisible into strategic advantage.
About Ainos, Inc.
Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.
Contact Information:
Feifei Shen
[email protected]
SOURCE: Ainos, Inc.
View the original press release on ACCESS Newswire
B.Finley--AMWN